StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Shanghai Stock Exchange:603392.SS
Sector
Location
Market Cap
USD 10.71 B
Share Price
USD 8.46
Avg Daily Volume
3,054,115
Change (1 day)
-1.57%
Change (1 year)
-5.50%
Change (YTD)
-12.30%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Revenue Per Share for the year ending December 31, 2024: USD 0.23
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Revenue Per Share is USD 0.23 for the year ending December 31, 2024, a -62.17% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Revenue Per Share for the year ending December 31, 2023 was USD 0.61, a -52.81% change year over year.
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 1.30, a 76.36% change year over year.
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 0.74, a 143.70% change year over year.
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 0.30, a 95.17% change year over year.
Competitors
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Moderna, Inc.
USD 30.49
MRNA
+0.21
0.69%
Swedish Orphan Biovitrum AB (publ)
USD 30.04
SOBI.ST
+0.32
1.09%
Ionis Pharmaceuticals, Inc.
USD 43.00
IONS
-0.59
-1.35%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.73
300122.SZ
-0.03
-1.17%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.15
1877.HK
+0.09
3.09%
Vaxcyte, Inc.
USD 33.25
PCVX
-0.02
-0.06%
Rhythm Pharmaceuticals, Inc.
USD 65.77
RYTM
-1.15
-1.72%
Hualan Biological Engineering Inc.
USD 2.21
002007.SZ
-0.00
-0.22%
Apogee Therapeutics, Inc.
USD 47.46
APGE
+3.14
7.08%
Apellis Pharmaceuticals, Inc.
USD 18.26
APLS
+0.44
2.47%
NewAmsterdam Pharma Company N.V.
USD 19.85
NAMS
+0.89
4.69%
Ligand Pharmaceuticals Incorporated
USD 114.58
LGND
+0.92
0.81%
Bavarian Nordic A/S
USD 27.27
BAVA.CO
+0.61
2.29%
Adaptive Biotechnologies Corporation
USD 11.80
ADPT
+0.32
2.79%
Immunocore Holdings plc
USD 33.02
IMCR
+0.27
0.82%
ARS Pharmaceuticals, Inc.
USD 16.52
SPRY
-0.23
-1.37%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Key Data
| Date | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share | Debt to Equity Ratio |
|---|
Competitors
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Moderna, Inc.
USD 30.49
MRNA
+0.21
0.69%
Swedish Orphan Biovitrum AB (publ)
USD 30.04
SOBI.ST
+0.32
1.09%
Ionis Pharmaceuticals, Inc.
USD 43.00
IONS
-0.59
-1.35%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.73
300122.SZ
-0.03
-1.17%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.15
1877.HK
+0.09
3.09%
Vaxcyte, Inc.
USD 33.25
PCVX
-0.02
-0.06%
Rhythm Pharmaceuticals, Inc.
USD 65.77
RYTM
-1.15
-1.72%
Hualan Biological Engineering Inc.
USD 2.21
002007.SZ
-0.00
-0.22%
Apogee Therapeutics, Inc.
USD 47.46
APGE
+3.14
7.08%
Apellis Pharmaceuticals, Inc.
USD 18.26
APLS
+0.44
2.47%
NewAmsterdam Pharma Company N.V.
USD 19.85
NAMS
+0.89
4.69%
Ligand Pharmaceuticals Incorporated
USD 114.58
LGND
+0.92
0.81%
Bavarian Nordic A/S
USD 27.27
BAVA.CO
+0.61
2.29%
Adaptive Biotechnologies Corporation
USD 11.80
ADPT
+0.32
2.79%
Immunocore Holdings plc
USD 33.02
IMCR
+0.27
0.82%
ARS Pharmaceuticals, Inc.
USD 16.52
SPRY
-0.23
-1.37%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%